ADAMTS-4 (aggrecanase-1): N-terminal activation mechanisms.

Arch Biochem Biophys

Pfizer Global Research and Development, 700 Chesterfield Parkway, Chesterfield, MO 60013, USA.

Published: December 2005

ADAMTS-4 (aggrecanase 1) is synthesized as a latent precursor protein that may require activation through removal of its prodomain before it can exert catalytic activity. We examined various proteinases as well as auto-activation under a wide range of conditions for removal of the prodomain and induction of enzymatic activity. The proprotein convertases, furin, PACE4, and PC5/6 efficiently removed the prodomain through cleavage at Arg(212)/Phe(213), generating an active enzyme. Of a broad range of proteases evaluated, only MMP-9 and trypsin were capable of removing the prodomain. In the presence of mercuric compounds, removal of the prodomain through autocatalysis was not observed, nor was it observed at temperatures from 22 to 65 degrees C, at ionic strengths from 0.1 to 1M, or at acidic/neutral pH. At basic pH 8-10, removal of the prodomain by autocatalysis occurred, generating an active enzyme. In conclusion, the pro-form of ADAMTS-4 is not catalytically active and only a limited number of mechanisms mediate its N-terminal activation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.abb.2005.09.018DOI Listing

Publication Analysis

Top Keywords

removal prodomain
16
n-terminal activation
8
generating active
8
active enzyme
8
prodomain autocatalysis
8
prodomain
6
adamts-4 aggrecanase-1
4
aggrecanase-1 n-terminal
4
activation mechanisms
4
mechanisms adamts-4
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!